This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Doris A. Trauner, MD

Arch Neurol. 1986;43(7):729.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

• the precise origin of Reye's syndrome is unknown, therapeutic approaches to the disease have three major goals: intensive supportive care, correction of identifiable metabolic abnormalities, and control of intracranial pressure (ICP).¹

For mild cases (stages I and II), the patient should be observed closely in a pediatric intensive care unit (such patients are subject to rapid and sudden deterioration in neurologic status) and treated with intravenous hypertonic (10% to 15%) glucose solutions at normal maintenance volumes. There is evidence that administration of hypertonic glucose solution to patients in the early stages may prevent disease progression.² If the disease progresses to stage III or worse, more aggressive therapy is necessary. The following recommendations are for treatment of patients with severe Reye's syndrome (stages III through V).

INTENSIVE SUPPORTIVE CARE

Children with Reye's syndrome are subject to hyperthermia, even in the absence of detectable infection, and to sudden respiratory . . . [Full Text PDF of this Article]

Author Affiliations
From the Departments of Neurosciences and Pediatrics, University of California School of Medicine, La Jolla.

Footnotes
Accepted for publication Oct 5, 1985.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?